ETF Managers Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,596
Closed -$22K 852
2022
Q2
$22K Buy
12,596
+698
+6% +$1.7K ﹤0.01% 734
2022
Q1
$43K Buy
11,898
+43
+0.4% +$211 ﹤0.01% 666
2021
Q4
$106K Sell
11,855
-2,275
-16% -$14.5K ﹤0.01% 636
2021
Q3
$104K Buy
14,130
+2,750
+24% +$23.2K ﹤0.01% 639
2021
Q2
$67K Sell
11,380
-15
-0.1% -$95 ﹤0.01% 633
2021
Q1
$139K Buy
+11,395
New +$226K ﹤0.01% 628

Other funds holding LHDX

ETF Managers Group's LHDX Position: Q3 2022 in Review

ETF Managers Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 12,596 shares — an estimated $22K sold.

ETF Managers Group first reported a position in LHDX in Q1 2021 and held it in 6 quarters. The position peaked at $139K in Q1 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • ETF Managers Group reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • ETF Managers Group sold 12,596 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $22K.
  • ETF Managers Group first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • ETF Managers Group's Lucira Health, Inc. Common Stock position peaked at $139K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.